Phase I/II Trial of Sequential Chemoradiotherapy Using a Novel Hypoxic Cell Radiosensitizer, Doranidazole (PR-350), in Patients With Locally Advanced Non–Small-Cell Lung Cancer (WJTOG-0002)-Reference-Cited by-同舟云学术

Phase I/II Trial of Sequential Chemoradiotherapy Using a Novel Hypoxic Cell Radiosensitizer, Doranidazole (PR-350), in Patients With Locally Advanced Non–Small-Cell Lung Cancer (WJTOG-0002)

Published:2007-11 Issue:3 Volume:69 Page:786-792
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Nishimura Yasumasa,Nakagawa Kazuhiko,Takeda Koji,Tanaka Masahiro,Segawa Yoshihiko,Tsujino Kayoko,Negoro Shunichi,Fuwa Nobukazu,Hida Toyoaki,Kawahara Masaaki,Katakami Nobuyuki,Hirokawa Keiko,Yamamoto Nobuyuki,Fukuoka Masahiro,Ariyoshi Yutaka

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference23 articles.

1. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non–small-cell lung cancer. A meta-analysis;Pritchard;Ann Intern Med,1996

2. Chemotherapy in non–small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials;Br Med J,1995

3. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients;Chevalier;J Natl Cancer Inst,1991

4. Rationale for chemoradiotherapy;Nishimura;Int J Clin Oncol,2004

5. Concurrent chemoradiotherapy in non–small cell lung cancer;Rowell;Cochrane Database Syst Rev,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nitroimidazole derivatives potentiated against tumor hypoxia: Design, synthesis, antitumor activity, molecular docking study, and QSAR study;Drug Development Research;2023-11

2. Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers;Molecules;2023-05-31

3. Nitroimidazole-sulfonamides as carbonic anhydrase IX and XII inhibitors targeting tumor hypoxia: Design, synthesis, molecular docking and molecular dynamics simulation;Journal of Molecular Structure;2022-09

4. DNA Damage Radiosensitizers Geared Towards Hydrated Electrons;Practical Aspects of Computational Chemistry V;2021-10-22

5. The Importance of the Tumor Microenvironment and Hypoxia in Delivering a Precision Medicine Approach to Veterinary Oncology;Frontiers in Veterinary Science;2020-11-12